Pine Valley Investments Ltd Liability »

Lineage Cell Therapeutics In shares owned by Pine Valley Investments Ltd Liability

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Pine Valley Investments Ltd Liability from 13F filings

Historical chart of Pine Valley Investments Ltd Liability investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Pine Valley Investments Ltd Liability consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Pine Valley Investments Ltd Liability

Quarter filed Position value Share count Share price at filing
2024-03-31 $27k 18k 1.48

More positions owned by Pine Valley Investments Ltd Liability

Spdr S&p 500 Etf Tr Call Call Option (Principal) (SPY)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
Apple Put Put Option (Principal) (AAPL)
Microsoft Corporation (MSFT)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Invesco Qqq Tr Put Put Option (Principal) (QQQ)
Assured Guaranty (AGO)
Pan Amern Silver Corp Put Put Option (Principal) (PAAS)
Alibaba Group Hldg Sponsored Ads (BABA)
Amazon Put Put Option (Principal) (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Kinross Gold Corp Call Call Option (Principal) (KGC)
Ishares Tr Put Put Option (Principal) (IWM)
Johnson & Johnson (JNJ)
Columbia Etf Tr I Diversifid Fxd (DIAL)

View all positions for Pine Valley Investments Ltd Liability

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Group
Logos Global Management
Defender Capital
Geode Capital Management
Raffles Associates
State Street Corporation
Prescott General Partners
MAI Wealth Advisors
DAFNA Capital Management
Bank of America Corporation
Northern Trust
Bridgeway Capital Management
Jpmorgan Chase & Co

View all funds holding Lineage Cell Therapeutics In